Search

BackgroundCaregivers play a pivotal role in maintaining an economically viable health care system, yet they are characterized by low levels of psychological well-being and consistently report unmet needs for psychological support. Mobile app–based (mobile health [mHealth]) interventions present a novel approach to both reducing stress and improving well-being. ObjectiveThis study aims to evaluate the effectiveness of a self-guided mobile app–based psychological intervention for people providing care to family or friends with a physical or mental disability. MethodsIn a randomized, single-blind, controlled trial, 183 caregivers recruited through the web were randomly allocated to either an intervention (n=73) or active control (n=110) condition. The intervention app contained treatment modules combining daily self-monitoring with third-wave (mindfulness-based) cognitive-behavioral therapies, whereas the active control app contained only self-monitoring features. Both programs were completed over a 5-week period. It was hypothesized that intervention app exposure would be associated with decreases in depression, anxiety, and stress, and increases in well-being, self-esteem, optimism, primary and secondary control, and social support. Outcomes were assessed at baseline, postintervention, and 3-4 months postintervention. App quality was also assessed. ResultsIn total, 25% (18/73) of the intervention participants were lost to follow-up at 3 months, and 30.9% (34/110) of the participants from the wait-list control group dropped out before the postintervention survey. The intervention group experienced reductions in stress (b=−2.07; P=.04) and depressive symptoms (b=−1.36; P=.05) from baseline to postintervention. These changes were further enhanced from postintervention to follow-up, with the intervention group continuing to report lower levels of depression (b=−1.82; P=.03) and higher levels of emotional well-being (b=6.13; P

Objective: This study aimed to evaluate whether the Therapist-assisted Online Parenting Strategies programme increased parenting behaviours known to be supportive of adolescents experiencing anxiety and/or depression. Secondary parenting outcomes of parental self-efficacy, parental accommodation, carer burden, parent–adolescent attachment, family functioning and parent distress were also examined, along with adolescent outcomes of anxiety and depression symptoms, suicidal ideation and sleep. Method: Seventy-one parents (94.4% females) and their adolescents (73.2% females) aged 12–18 years (Mean = 15.02, SD = 1.56) being treated for depression and/or anxiety in Australia were recruited into a single-arm double-baseline open-label trial. Parents received Therapist-assisted Online Parenting Strategies, which comprised up to nine web-based modules each supplemented with coaching sessions via videoconferencing. Outcomes were analysed using latent growth curve modelling to determine if changes to outcomes at post-intervention (4 month post-second baseline) exceeded changes between two baselines measured 1 month apart. Results: Sixty-five parents (91.6%) completed at least one module of the online parenting intervention and on average received nine coaching sessions (SD = 2). Parenting behaviours targeted by Therapist-assisted Online Parenting Strategies improved at post-intervention (Cohen's d = 1.16, 95% confidence interval [0.78, 1.51]). Parent-reported parental self-efficacy and parent−adolescent attachment increased (Cohen's d = 1.44 [1.05, 1.82] and 0.39 [0.05, 0.74], respectively), while impairments to family functioning and parent distress decreased (Cohen's d = −0.51 [−0.86, −0.16] and −0.84 [−1.23, −0.44], respectively). Changes to adolescent anxiety, depression and sleep were not significant. Conclusion: The Therapist-assisted Online Parenting Strategies intervention improved self-reported parenting behaviours, parental self-efficacy, parent levels of distress, parent–adolescent attachment, and family functioning in parents with adolescents being treated for anxiety and/or depression. However, significant changes in adolescent mental health and sleep outcomes at post-intervention were not observed. The usefulness of a therapist-supported online parenting programme in addressing a service gap for parents seeking professional help is indicated. Trial Registration: Australian New Zealand Clinical Trials Registry Number (ACTRN) 12618000290291, prospectively registered on 26 February 2018; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=368031 [ABSTRACT FROM AUTHOR]

The self-healing behavior of a modified ureido-amide based thermoplastic hybrid elastomer was investigated by increasing the concentration of non-reversible (covalent) bonds compared to reversible (hydrogen) bonds. A crosslinked polymer network was synthesized using varying amounts of diglycidylether of bisphenol A and reacting with the ureido-amide thermoplastic. Increasing epoxy content produced a more rigid and thermally stable hybrid network, which in turn decreased overall thermo-reversible or healing behavior. Fracture toughness recoveries varied from 25% for the system containing the greatest number of covalent bonds to well over 200% for systems containing higher thermoplastic content. Substantial levels of healing, about 62% recovery, were still achieved despite the crosslinked network having a Tg above room temperature, 31°C as measured by differential scanning calorimetry (DSC). Dynamic mechanical thermal analysis was used to monitor thermo-reversible behavior of the elastic moduli and thus probe molecular mobility within the glassy state. The extent and rate of recovery of the elastic modulus was dominated by the extent of thermal activation above the glass transition temperature. Fourier transform infrared spectroscopic and DSC studies confirmed that reacting the thermoplastic with an epoxy resin produced a covalently bonded crosslinked network and the epoxide groups were completely consumed. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013 [ABSTRACT FROM AUTHOR]

This article explores the use of two β nucleants to improve the fracture behavior of filled and unfilled homo-polypropylene (PP). The first was based upon an organic quinacridone, whereas the second was based upon the inorganic calcium pimelate. Formulations containing various concentrations of nucleant were prepared using single screw extrusion and then characterized by X-ray diffraction, differential scanning calorimetry (DSC), Izod impact strength, and tensile testing. The quinacridone nucleating agent produced higher levels of β crystallinity and better improvement in strain to failure, whereas the calcium pimelate imparted greater improvement in impact strength regardless of whether the PP was filled or unfilled. No direct relationship between β crystallinity and fracture properties was observed though synergistic enhancement in impact strength was evident. By varying the concentration of calcium carbonate in the calcium pimelate from 10 : 1, 5 : 1, 2 : 1, and 1 : 1 weight composition of calcium carbonate to pimelic acid, similar property enhancements were achieved regardless of composition although the 10 : 1 sample did produce superior elongation to break. The importance of cooling rate on microstructure within each sample was explored via a through the thickness study using DSC and nano-indenting methods. Variations in the β content through the thickness were related to cooling and found to be independent of sample composition and processing. Elastic properties varied inversely with β content. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013 [ABSTRACT FROM AUTHOR]

The blood-brain barrier (BBB) plays a crucial role in the central nervous system by tightly regulating the influx and efflux of biological substances between the brain parenchyma and peripheral circulation. Its restrictive nature acts as an obstacle to protect the brain from potentially noxious substances such as blood-borne toxins, immune cells, and pathogens. Thus, the maintenance of its structural and functional integrity is vital in the preservation of neuronal function and cellular homeostasis in the brain microenvironment. However, the barrier's foundation can become compromised during neurological or pathological conditions, which can result in dysregulated ionic homeostasis, impaired transport of nutrients, and accumulation of neurotoxins that eventually lead to irreversible neuronal loss. Initially, the BBB is thought to remain intact during neurodegenerative diseases, but accumulating evidence as of late has suggested the possible association of BBB dysfunction with Parkinson's disease (PD) pathology. The neurodegeneration occurring in PD is believed to stem from a myriad of pathogenic mechanisms, including tight junction alterations, abnormal angiogenesis, and dysfunctional BBB transporter mechanism, which ultimately causes altered BBB permeability. In this review, the major elements of the neurovascular unit (NVU) comprising the BBB are discussed, along with their role in the maintenance of barrier integrity and PD pathogenesis. We also elaborated on how the neuroendocrine system can influence the regulation of BBB function and PD pathogenesis. Several novel therapeutic approaches targeting the NVU components are explored to provide a fresh outlook on treatment options for PD., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)